Clinical Trials Browser

Phase 1 × defactinib × 90 days × Clear all

NCT05636514 2026-03-18

CELESTIAL-MDS

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT03875820 2026-03-10

FRAME

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Endometrioid

NCT07318324 2026-01-06

Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

Phase 1 Not yet recruiting

Phase IB